MedPath

Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure

Phase 2
Completed
Conditions
Heart Failure, Congestive
Registration Number
NCT00202579
Lead Sponsor
Institut de Recherches Internationales Servier
Brief Summary

To evaluate the effects on heart function of ivabradine administered to patients with severe chronic heart failure

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • systolic congestive heart failure
  • sinus rhythm, HR >= 80bpm
Read More
Exclusion Criteria
  • unstable cardiovascular condition
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Systolic and diastolic blood pressure
Haemodynamic parameters
Twelve-lead ECG
Secondary Outcome Measures
NameTimeMethod
Neurohormones
Echocardiography

Trial Locations

Locations (1)

Policlinico San Matteo

🇮🇹

Pavia, Italy

© Copyright 2025. All Rights Reserved by MedPath